Compare OIS & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OIS | BWAY |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.7M | 450.8M |
| IPO Year | 2000 | N/A |
| Metric | OIS | BWAY |
|---|---|---|
| Price | $11.16 | $14.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.00 | $13.25 |
| AVG Volume (30 Days) | ★ 782.9K | 169.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.73 | $309.69 |
| Revenue Next Year | $5.36 | $26.21 |
| P/E Ratio | ★ N/A | $81.98 |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $3.33 | $7.84 |
| 52 Week High | $14.50 | $26.63 |
| Indicator | OIS | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 43.89 | 51.40 |
| Support Level | $5.72 | $14.56 |
| Resistance Level | $12.79 | $16.63 |
| Average True Range (ATR) | 0.49 | 0.72 |
| MACD | -0.09 | 0.48 |
| Stochastic Oscillator | 21.04 | 92.73 |
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.